Targeting mesothelin in cancer

Cem Elbi · 2023

Read Targeting mesothelin in cancer by Cem Elbi (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10701581.txt.

Description

Cem Elbi, writing in 2023, reviews efforts to aim cancer drugs at a protein called mesothelin. The protein sits on the surface of lining cells in the chest and belly, but tumors of many kinds carry far more of it. That contrast makes it an inviting target: hit the tumor, spare most healthy tissue.

Elbi discusses a new study that built a small antibody piece against the protein and linked it to a cell-killing drug. The piece was also fused with part of a standard antibody to make it last longer in the body, and its grip on the target was mapped by crystal analysis. Other attack routes include plain antibodies, toxins, vaccines, and engineered immune cells. Trials so far show fair safety but modest effect.

Catalog record

CREATORCem Elbi
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE8 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10701581

Browse the full library · About the Tower of Babel